Blood-based biomarkers for malignant gliomas

Detection of phosphoinositide-3-kinase, catalytic, and alpha polypeptide (PIK3CA) mutations in matched tissue and plasma samples from patients with metastatic breast cancer.

(2017) P. Angenendt et al.   JOURNAL OF CLINICAL ONCOLOGY

RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls

(2012) Mikkel Noerholm et al.   BMC CANCER

Blood Alterations Preceding Clinical Manifestation of Glioblastoma

(2012) Aysegül Ilhan-Mutlu et al.   CANCER INVESTIGATION

Pre- and post-operative plasma glial fibrillary acidic protein levels in patients with newly diagnosed gliomas

(2012) Hatim Husain et al.   JOURNAL OF NEURO-ONCOLOGY

Detection of IDH1 mutation in the plasma of patients with glioma

(2012) B. Boisselier et al.   NEUROLOGY

Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept

(2011) J. F. de Groot et al.   CLINICAL CANCER RESEARCH

Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer

(2011) Andrew J. Armstrong et al.   EUROPEAN UROLOGY

The natural history of extracranial metastasis from glioblastoma multiforme

(2011) Melody Lun et al.   JOURNAL OF NEURO-ONCOLOGY

A specific miRNA signature in the peripheral blood of glioblastoma patients

(2011) Patrick Roth et al.   JOURNAL OF NEUROCHEMISTRY

Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades

(2011) I. Lavon et al.   NEURO-ONCOLOGY

Microdialysis for assessing intratumoral drug disposition in brain cancers: a tool for rational drug development

(2010) Jaishri Blakeley et al.   Expert Opinion on Drug Metabolism & Toxicology

Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma

(2010) Tracy T. Batchelor et al.   JOURNAL OF CLINICAL ONCOLOGY

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

(2010) Patrick Y. Wen et al.   JOURNAL OF CLINICAL ONCOLOGY

Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing

(2010) R. J. Leary et al.   Science Translational Medicine

P16 PROMOTER METHYLATION IN THE SERUM AS A BASIS FOR THE MOLECULAR DIAGNOSIS OF GLIOMAS

(2009) Toshihiko Wakabayashi et al.   NEUROSURGERY

Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study

(2008) Jaishri O. Blakeley et al.   JOURNAL OF NEURO-ONCOLOGY

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

(2008) Dieta Brandsma et al.   LANCET ONCOLOGY

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

(2008) Johan Skog et al.   NATURE CELL BIOLOGY

Circulating mutant DNA to assess tumor dynamics

(2008) Frank Diehl et al.   NATURE MEDICINE

Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults

(2008) Santosh Kesari et al.   NEURO-ONCOLOGY